MUSANTE, ILARIA
 Distribuzione geografica
Continente #
EU - Europa 3.815
Totale 3.815
Nazione #
IT - Italia 3.815
Totale 3.815
Città #
Genova 2.026
Genoa 874
Rapallo 464
Vado Ligure 446
Bordighera 5
Totale 3.815
Nome #
Genetic inactivation of mGlu5 receptor improves motor coordination in the Grm1crv4 mouse model of SCAR13 ataxia 179
In-vivo effects of knocking-down metabotropic glutamate receptor 5 in the SOD1G93A mouse model of amyotrophic lateral sclerosis. 169
Compensatory Molecular and Functional Mechanisms in Nervous System of the Grm1crv4 Mouse Lacking the mGlu1 Receptor: A Model for Motor Coordination Deficits. 156
Assessment of copy number variations in 120 patients with Poland syndrome 152
Goblet Cell Hyperplasia Requires High Bicarbonate Transport To Support Mucin Release 148
Phenotypic characterization of Grm1crv4 mice reveals a functional role for the type 1 metabotropic glutamate receptor in bone mineralization 143
De novo deletion of chromosome 11q12.3 in monozygotic twins affected by Poland Syndrome 125
Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis 123
mGluR1 and mGluR5 knock-down improves survival, motor skills and disease progression in amyotrophic lateral sclerosis mouse model 109
Compensatory molecular and functional mechanisms in neurons of the Grm1crv4 mouse, a murine model for ataxia lacking the mGlu1 receptor. 105
Knocking-down mGluR1 and mGluR5 in the SOD1/G93A mouse model of amyotrophic lateral sclerosis ameliorates survival and disease progression 102
Targeting Group I Metabotropic Glutamate Receptors in Amyotrophic Lateral Sclerosis 101
Amyotrophic lateral sclerosis and excitotoxicity: role of Group I metabotropic glutamate receptors 99
Group I metabotropic glutamate receptors tune excitotoxicity in amyotrophic lateral sclerosis 97
GROUP I METABOTROPIC GLUTAMATE RECEPTORS AND NEUROTOXICITY IN AMYOTROPHIC LATERAL SCLEROSIS 97
Knocking-down mGlu1 receptors prolongs survival and ameliorates disease progression in the SOD1/G93A mouse model of ALS. 96
Compensatory molecular and functional mechanisms in neurons of the Grm1crv4 mouse, a murine model for ataxia lacking the mGlu1 receptor 95
Targeting group i metabotropic glutamate receptors in experimental als. 88
Reducing the expression of mGlu1 and mGlu5 receptors ameliorates survival and disease progression in SOD1G93A mice 85
Knocking down mglu1 receptors prolongs survival and improves symptomatology in a mouse model of amyotrophic lateral sclerosis 85
Group I metabotropic glutamate receptors in ALS: knocking-down mGlu1 receptors ameliorates survival and disease progression in SOD1/G93A mice. 82
Ionocytes and CFTR Chloride Channel Expression in Normal and Cystic Fibrosis Nasal and Bronchial Epithelial Cells 80
Partial deletion of mGluR1 receptors prolongs life span and ameliorates motor skills and biochemical and cellular parameters in a mouse model of experimental ALS 77
Reducing excitotoxicity knocking down mGluR1: prolonged survival and improved symptomatology of SOD1/G93A mouse model of ALS 77
Genetic inactivation of metabotropic glutamate 5 (mGlu5) receptor ameliorates motor coordination in the Grm1crv4 mouse model of SCAR13 ataxia 77
Knocking-down mGluR1 and mGluR5 in SOD1G93A mice ameliorates survival and disease progression 77
Inactivation of the Grm5 gene improves motor coordination defects in the Grm1crv4 mouse model of SCAR13 ataxia 75
Knocking-down mGluR1 and mGluR5 in the SOD1/G93A mouse model of amyotrophic lateral sclerosis ameliorates survival and disease progression 69
Phenotypic Characterization of Grm1crv4 Mice Reveals a Functional Role for the Type 1 Metabotropic Glutamate Receptor in the Skeleton 64
Intermolecular interactions in the TMEM16A dimer controlling channel activity 59
The Autophagy Inhibitor Spautin-1 Antagonizes Rescue of Mutant CFTR Through an Autophagy-Independent and USP13-Mediated Mechanism 57
Partial rescue of f508del-cftr stability and trafficking defects by double corrector treatment 55
Whole exome sequencing (WES) and functional analyses suggest synergistic effects of deleterious variants in two candidate genes for Poland Syndrome 55
Brain Organoids as Model Systems for Genetic Neurodevelopmental Disorders 54
Targeting alternative splicing as a potential therapy for episodic ataxia type 2 54
Genotype-phenotype correlations and disease mechanisms in PEX13-related Zellweger spectrum disorders 53
A Phenotypic-Driven Approach for the Diagnosis of WOREE Syndrome 52
Two CFTR mutations within codon 970 differently impact on the chloride channel functionality 51
Genetic Downregulation of the Metabotropic Glutamate Receptor Type 5 Dampens the Reactive and Neurotoxic Phenotype of Adult ALS Astrocytes 50
Comprehensive analysis of combinatorial pharmacological treatments to correct nonsense mutations in the cftr gene 48
Peripheral localization of the epithelial sodium channel in the apical membrane of bronchial epithelial cells 44
Increased expression of ATP12A proton pump in cystic fibrosis airways 44
Vesicular glutamate release from feeder-free hiPSC-derived neurons 42
Loss of Neuron Navigator 2 Impairs Brain and Cerebellar Development 38
Generation of an induced pluripotent stem cell line (IGGi002A) from nasal cells of a cystic fibrosis patient homozygous for the G542X-CFTR mutation 36
mGlu5 receptor negative allosteric modulation reduces the aberrant cellular reactivity and neurotoxicity of reactive human astrocytes differentiated from fibroblast of SOD1 and C9orf72 ALS patients 29
Reactive Astrocytes from patients affected by Amyotrophic Lateral Sclerosis: how mGlu5 receptor modulation affects pathological features 22
Allelic heterogeneity and abnormal vesicle recycling in PLAA-related neurodevelopmental disorders 21
De novo variants in DENND5B cause a neurodevelopmental disorder 19
Generation of two iPSC lines from Mowat-Wilson syndrome patients carrying heterozygous ZEB2 mutations 14
Reactive phenotype and oxidative stress in i-Astrocytes from patients affected by Amyotrophic Lateral Sclerosis: how the mGluR5 negative allosteric modulator CTEP affects these pathological features 13
KCa3.1 differentially regulates trachea and bronchi epithelial gene expression in a chronic-asthma mouse model 7
Totale 3.949
Categoria #
all - tutte 14.542
article - articoli 9.884
book - libri 0
conference - conferenze 4.658
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.084


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020254 0 0 0 0 0 0 0 0 48 118 70 18
2020/2021305 13 6 43 31 6 16 35 48 32 37 26 12
2021/2022422 6 35 28 41 17 22 16 100 25 40 27 65
2022/2023541 46 50 7 35 88 83 1 39 99 2 76 15
2023/2024392 13 48 9 53 27 82 29 14 19 15 25 58
2024/2025871 46 83 25 81 138 118 105 262 13 0 0 0
Totale 3.949